3-methylcholanthrene has been researched along with Angiogenesis, Pathologic in 12 studies
Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two animal tumor models were used: fibrosarcoma induced by 3-methylcholanthrene (3-MCA) in FVB/N mice invalidated for AT2R (AT2R-KO) and carcinoma LL/2 cells injected in C57BL/6N mice treated with AT2R antagonist PD123,319." | 3.76 | Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. ( Chalopin, M; Clere, N; Coqueret, O; Corre, I; Delneste, Y; Faure, S; Guihot, AL; Hein, L; Henrion, D; Morel, A; Paris, F; Vessières, E, 2010) |
| "The aim of the study was the evaluation of angiogenesis processes in fibrosarcoma induced by 3-methylcholanthrene (3-Mc) in reference to the number of mast cells (MCs)." | 3.71 | Preliminary evaluation of mast cells and angiogenesis processes in experimental fibrosarcoma. ( Chyczewski, L; Kasacka, I; Sawicki, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voronov, E | 1 |
| Reich, E | 1 |
| Dotan, S | 1 |
| Dransh, P | 1 |
| Cohen, I | 1 |
| Huszar, M | 1 |
| Fogel, M | 1 |
| Kleinman, HK | 1 |
| White, RM | 1 |
| Apte, RN | 1 |
| Clere, N | 1 |
| Corre, I | 1 |
| Faure, S | 1 |
| Guihot, AL | 1 |
| Vessières, E | 1 |
| Chalopin, M | 1 |
| Morel, A | 1 |
| Coqueret, O | 1 |
| Hein, L | 1 |
| Delneste, Y | 1 |
| Paris, F | 1 |
| Henrion, D | 1 |
| Karoor, V | 1 |
| Le, M | 1 |
| Merrick, D | 1 |
| Fagan, KA | 1 |
| Dempsey, EC | 1 |
| Miller, YE | 1 |
| Manegold, PC | 1 |
| Hutter, J | 1 |
| Pahernik, SA | 1 |
| Messmer, K | 1 |
| Dellian, M | 1 |
| TEDESCHI, LG | 1 |
| GEORGE, WS | 1 |
| BOTTA, GC | 1 |
| TEDESCHI, CG | 1 |
| Yamakawa, S | 1 |
| Asai, T | 1 |
| Uchida, T | 1 |
| Matsukawa, M | 1 |
| Akizawa, T | 1 |
| Oku, N | 2 |
| Wood, PA | 1 |
| Bove, K | 1 |
| You, S | 1 |
| Chambers, A | 1 |
| Hrushesky, WJ | 1 |
| Zhang, Y | 1 |
| Deng, Y | 1 |
| Luther, T | 1 |
| Müller, M | 1 |
| Ziegler, R | 1 |
| Waldherr, R | 1 |
| Stern, DM | 1 |
| Nawroth, PP | 1 |
| Maity, P | 2 |
| Chakraborty, S | 2 |
| Bhattacharya, P | 2 |
| Kurohane, K | 1 |
| Tominaga, A | 1 |
| Sato, K | 1 |
| North, JR | 1 |
| Namba, Y | 1 |
| Sawicki, B | 1 |
| Kasacka, I | 1 |
| Chyczewski, L | 1 |
12 other studies available for 3-methylcholanthrene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Topics: Animals; Aorta, Thoracic; Cell Line, Tumor; Chick Embryo; Culture Media, Conditioned; Cytokines; End | 2010 |
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell | 2010 |
Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/EGFR-dependent mechanism.
Topics: Animals; Antioxidants; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Blotting, We | 2012 |
Platelet-endothelial interaction in tumor angiogenesis and microcirculation.
Topics: Animals; Blood Flow Velocity; Blood Platelets; Calcimycin; Calcium; Carcinoma, Lewis Lung; Cell Move | 2003 |
An experimental evaluation of the role of regional chronic lymphoedema in neovascular growth.
Topics: Lymphedema; Methylcholanthrene; Neoplasms; Neoplasms, Vascular Tissue; Neovascularization, Pathologi | 1963 |
(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Cell M | 2004 |
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis.
Topics: Animals; Blood Vessels; Capillary Permeability; Estrous Cycle; Female; Fibroblast Growth Factor 2; G | 2005 |
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.
Topics: Animals; Cell Adhesion Molecules; DNA, Complementary; Endothelial Growth Factors; Endothelium, Vascu | 1994 |
Angiogenesis a putative new approach in glutamine related therapy.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cervix Uteri; Female; Glutaminase; Glutamine; Liver; Male; Methyl | 1999 |
Neovascularisation offers a new perspective to glutamine related therapy.
Topics: Angiogenesis Inhibitors; Animals; Carcinogens; Carcinoma, Ehrlich Tumor; Drug Screening Assays, Anti | 2000 |
Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Topics: Animals; Disease Models, Animal; Liposomes; Male; Methylcholanthrene; Mice; Mice, Inbred BALB C; Neo | 2001 |
Preliminary evaluation of mast cells and angiogenesis processes in experimental fibrosarcoma.
Topics: Animals; Biomarkers, Tumor; Carcinogens; Fibrosarcoma; Immunohistochemistry; Male; Mast Cells; Methy | 2002 |